All Stories

  1. The UK's pandemic influenza research portfolio: a model for future research on emerging infections
  2. Helping GPs predict asthma attacks using Machine Learning
  3. Exogenous sex steroid hormones and asthma in females: protocol for a population-based retrospective cohort study using a UK primary care database
  4. Accuracy and utility of using administrative healthcare databases to identify people with epilepsy: a protocol for a systematic review and meta-analysis
  5. Retrospective cohort study of breast cancer incidence, health service use and outcomes in Europe: a study of feasibility
  6. Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease
  7. External validation of a COPD prediction model using population-based primary care data: a nested case-control study
  8. Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study
  9. Projecting the COPD population and costs in England and Scotland: 2011 to 2030
  10. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases
  11. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children
  12. Will moving from Read coding system to SNOMED-CT improve coding in primary care?
  13. Building a recruitment database for asthma trials: a conceptual framework for the creation of the UK Database of Asthma Research Volunteers
  14. Cardiovascular and neuropsychiatric risks of varenicline – Authors' reply
  15. Effectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocol
  16. Ethnic variations in asthma hospital admission, readmission and death: a retrospective, national cohort study of 4.62 million people in Scotland
  17. Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? – Authors' reply
  18. Challenges of harmonising data from UK national health surveys: a case study of attempts to estimate the UK prevalence of asthma
  19. Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
  20. Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study
  21. Ethnic variations in morbidity and mortality from lower respiratory tract infections: a retrospective cohort study
  22. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
  23. Risk of respiratory hospitalization and death, readmission and subsequent mortality: scottish health and ethnicity linkage study
  24. Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease
  25. Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales—a study protocol
  26. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
  27. Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD
  28. Prevalence of polypharmacy in a Scottish primary care population
  29. Epidemiology of Asthma
  30. Integrating Telehealth Care-Generated Data With the Family Practice Electronic Medical Record: Qualitative Exploration of the Views of Primary Care Staff
  31. Models for estimating projections for the prevalence and disease burden of chronic obstructive pulmonary disease (COPD): systematic review protocol
  32. Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
  33. Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE) - use of a unique community and laboratory national linked dataset
  34. Association Between Prescribing of Cardiovascular and Psychotropic Medications and Hospital Admission for Falls or Fractures
  35. Practical methodological strategies for individual patient data systematic reviews
  36. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study
  37. Pandemic influenza vaccination for healthcare workers in primary care: good progress, but higher uptake required
  38. Diagnosis and treatment of depression following routine screening in patients with coronary heart disease or diabetes: a database cohort study
  39. Adequate Levels of Adherence with Controller Medication Is Associated with Increased Use of Rescue Medication in Asthmatic Children
  40. Factors associated with duration of new antidepressant treatment: analysis of a large primary care database
  41. A retrospective cohort study assessing patient characteristics and the incidence of cardiovascular disease using linked routine primary and secondary care data
  42. Seasonal Influenza Vaccine Effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set
  43. Risk of prostate cancer associated with benign prostate disease: a primary care case–control study
  44. Five-Year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction
  45. Paracetamol prescribing in primary care: too little and too much?
  46. Impact of the pay-for-performance contract and the management of hypertension in Scottish primary care: a 6-year population-based repeated cross-sectional study
  47. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice
  48. Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysis
  49. Incidence, prevalence, and trends of general practitioner–recorded diagnosis of peanut allergy in England, 2001 to 2005
  50. Using Routinely Collected Prescribing Data to Determine Drug Persistence for the Purpose of Pharmacovigilance
  51. Using primary care prescribing databases for pharmacovigilance
  52. Considerable differences exist between prevalent and incident myocardial infarction cohorts derived from the same population
  53. A retrospective observational study comparing rescue medication use in children on combined versus separate long-acting  -agonists and corticosteroids
  54. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients
  55. Vaccine effectiveness in pandemic influenza – primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.
  56. Adrenaline is first line treatment for the emergency treatment of anaphylaxis
  57. Use and safety of long-acting β2-agonists for pediatric asthma
  58. Trends in the epidemiology of asthma in England: a national study of 333,294 patients
  59. Trends in the epidemiology of smoking recorded in UK general practice
  60. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland
  61. Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases
  62. Five year prognosis in patients with angina identified in primary care: incident cohort study
  63. Trends in the epidemiology and prescribing of medication for eczema in England
  64. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People
  65. Incidence and prevalence of multiple allergic disorders recorded in a national primary care database
  66. Introduction of a new incentive and target-based contract for family physicians in the UK: good for older patients with diabetes but less good for women?
  67. The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
  68. Adolescent Females and Hormonal Contraception: A Retrospective Study in Primary Care
  69. Evidence for prolonged prescribing of aspirin–clopidogrel combination in Scottish primary care
  70. The Potential for Interaction between Warfarin and Coprescribed Medication
  71. Understanding the reasons for poor asthma outcomes in ethnic minorities: welcome progress, but important questions remain
  72. The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care
  73. Will Systematized Nomenclature of Medicine-Clinical Terms improve our understanding of the disease burden posed by allergic disorders?
  74. The filaggrin gene mutation, atopic dermatitis and asthma
  75. Are different groups of patients with stroke more likely to be excluded from the new UK general medical services contract? A cross-sectional retrospective analysis of a large primary care population
  76. Authors' response: Homeopathy is safe and does not lack positive evidence in clinical trials/Scottish GPs use of Homeopathy
  77. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
  78. Gender-specific presentations for asthma, allergic rhinitis and eczema in primary care
  79. Homoeopathic and herbal prescribing in general practice in Scotland
  80. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study
  81. Effect of the UK Incentive-Based Contract on the Management of Patients With Stroke in Primary Care
  82. Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders
  83. Adolescent use of the combined oral contraceptive pill: a retrospective observational study
  84. Changing incidence of respiratory presentations in primary care fact or artefact?
  85. Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care
  86. Acute drug prescribing to children on chronic antiepilepsy therapy and the potential for adverse drug interactions in primary care
  87. Paediatric homoeopathy in general practice: where, when and why?
  88. Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology
  89. Evidence for inequalities in the management of coronary heart disease in Scotland
  90. National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland
  91. Off-label prescribing to children in primary care: retrospective observational study
  92. Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study
  93. Inadequacies in UK primary care allergy services: national survey of current provisions and perceptions of need
  94. Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care
  95. Burden of corticosteroids in children with asthma in primary care: retrospective observational study
  96. Coincidence of immune-mediated diseases driven by Th1 and Th 2 subsets suggests a common aetiology. A population-based study using computerized General Practice data